BioCentury
ARTICLE | Company News

Dyax, Five Prime deal

May 2, 2011 7:00 AM UTC

Dyax and Five Prime partnered to discover and develop antibodies for undisclosed indications. Dyax will use its phage display technology to identify antibodies against multiple undisclosed targets sup...